Hearing: “The Cost of Being a Public Company in Light of Sarbanes-Oxley and the Federalization of Corporate Governance”

Subcommittee on Capital Markets, Securities, and Investment (Committee on Financial Services)

Tuesday, July 18, 2017 (10:00 AM)

2128 RHOB
Washington, D.C.

Witnesses

Mr. John Berlau
Senior Fellow, Competitive Enterprise Institute

Added 07/18/2017 at 01:59 PM
  • Witness Statement [PDF] Added 07/18/2017 at 02:00 PM
  • Witness Truth in Testimony [PDF] Added 07/19/2017 at 04:04 PM

Mr. John Blake
Senior Vice President of Finance, aTyr Pharma, Inc.

Added 07/18/2017 at 01:59 PM
  • Witness Statement [PDF] Added 07/18/2017 at 02:00 PM
  • Witness Truth in Testimony [PDF] Added 07/19/2017 at 04:04 PM

Professor J. Robert Brown Jr.
Lawrence W. Treece Professor of Corporate Governance, Director, Corporate and Commercial Law Program, University of Denver Sturm College of Law

Added 07/18/2017 at 01:59 PM
  • Witness Statement [PDF] Added 07/18/2017 at 02:00 PM
  • Witness Truth in Testimony [PDF] Added 07/19/2017 at 04:04 PM

Mr. Thomas Farley
President, NYSE Group

Added 07/18/2017 at 01:59 PM
  • Witness Statement [PDF] Added 07/18/2017 at 02:00 PM
  • Witness Truth in Testimony [PDF] Added 07/19/2017 at 04:04 PM

Mr. Thomas Quaadman
Executive Vice President, Center for Capital Market Competitiveness, U.S. Chamber of Commerce

Added 07/18/2017 at 01:59 PM
  • Witness Statement [PDF] Added 07/18/2017 at 02:00 PM
  • Witness Truth in Testimony [PDF] Added 07/19/2017 at 04:04 PM

First Published: July 14, 2017 at 04:20 PM
Last Updated: July 19, 2017 at 04:04 PM